Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.
Identifieur interne : 002892 ( Ncbi/Merge ); précédent : 002891; suivant : 002893Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.
Auteurs : Nina O. Nielsen [Danemark] ; Paul E. Simonsen ; Peter Dalgaard ; Henrik Krarup ; Pascal Magnussen ; Stephen Magesa ; Henrik FriisSource :
- The American journal of tropical medicine and hygiene [ 0002-9637 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte, Antihelminthiques (pharmacologie), Charge virale, Diéthylcarbamazine (pharmacologie), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Infections à VIH (), Infections à VIH (immunologie), Infections à VIH (virologie), Lymphocytes T CD4+ (), Lymphocytes T CD4+ (cytologie), Lymphocytes T CD8+ (), Lymphocytes T CD8+ (cytologie), Méthode en double aveugle, Placebo, Rapport CD4-CD8, Tanzanie, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Études croisées.
- MESH :
- cytologie : Lymphocytes T CD4+, Lymphocytes T CD8+.
- immunologie : Infections à VIH.
- pharmacologie : Antihelminthiques, Diéthylcarbamazine.
- traitement médicamenteux : Filariose lymphatique.
- virologie : Infections à VIH.
- Adulte, Charge virale, Filariose lymphatique, Humains, Infections à VIH, Lymphocytes T CD4+, Lymphocytes T CD8+, Méthode en double aveugle, Placebo, Rapport CD4-CD8, Tanzanie, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Études croisées.
English descriptors
- KwdEn :
- Adult, Anthelmintics (pharmacology), CD4-CD8 Ratio, CD4-Positive T-Lymphocytes (cytology), CD4-Positive T-Lymphocytes (drug effects), CD8-Positive T-Lymphocytes (cytology), CD8-Positive T-Lymphocytes (drug effects), Cross-Over Studies, Diethylcarbamazine (pharmacology), Double-Blind Method, Elephantiasis, Filarial (complications), Elephantiasis, Filarial (drug therapy), HIV Infections (complications), HIV Infections (immunology), HIV Infections (virology), HIV-1, Humans, Placebos, Tanzania, Viral Load.
- MESH :
- chemical , pharmacology : Anthelmintics, Diethylcarbamazine.
- geographic : Tanzania.
- complications : Elephantiasis, Filarial, HIV Infections.
- cytology : CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes.
- drug effects : CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes.
- drug therapy : Elephantiasis, Filarial.
- immunology : HIV Infections.
- virology : HIV Infections.
- Adult, CD4-CD8 Ratio, Cross-Over Studies, Double-Blind Method, HIV-1, Humans, Placebos, Viral Load.
Abstract
We assessed the effect of anti-filarial treatment (diethylcarbamazine, DEC) on HIV load, CD4%, and CD4/CD8 ratio in HIV-positive individuals with and without infection with the filarial parasite Wuchereria bancrofti in a randomized, double-blind, placebo-controlled cross-over trial. The study was conducted in Tanga Region, Tanzania, in 2002 and involved 27 adults. A significant decrease in HIV load (54%) and an insignificant increase in CD4% were observed in the HIV-positive individuals with filarial co-infection at 12 weeks after treatment. HIV load and CD4% both increased, although not statistically significantly, in the HIV-positive individuals without filarial infection. The findings suggest that DEC affected HIV load through its effect on the filarial infection rather than through a direct (pharmacodynamic) effect on HIV. Global efforts to control lymphatic filariasis by annual mass treatment with DEC may have a beneficial effect on the HIV/AIDS epidemic in areas where HIV and lymphatic filariasis co-exist.
PubMed: 17827369
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003530
- to stream PubMed, to step Curation: 003530
- to stream PubMed, to step Checkpoint: 003530
Links to Exploration step
pubmed:17827369Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.</title>
<author><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name>
<affiliation wicri:level="3"><nlm:affiliation>DBL-Centre for Health Research and Development, University of Copenhagen, Copenhagen, Denmark. nnielsen@dblnet.dk</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>DBL-Centre for Health Research and Development, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
</author>
<author><name sortKey="Dalgaard, Peter" sort="Dalgaard, Peter" uniqKey="Dalgaard P" first="Peter" last="Dalgaard">Peter Dalgaard</name>
</author>
<author><name sortKey="Krarup, Henrik" sort="Krarup, Henrik" uniqKey="Krarup H" first="Henrik" last="Krarup">Henrik Krarup</name>
</author>
<author><name sortKey="Magnussen, Pascal" sort="Magnussen, Pascal" uniqKey="Magnussen P" first="Pascal" last="Magnussen">Pascal Magnussen</name>
</author>
<author><name sortKey="Magesa, Stephen" sort="Magesa, Stephen" uniqKey="Magesa S" first="Stephen" last="Magesa">Stephen Magesa</name>
</author>
<author><name sortKey="Friis, Henrik" sort="Friis, Henrik" uniqKey="Friis H" first="Henrik" last="Friis">Henrik Friis</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17827369</idno>
<idno type="pmid">17827369</idno>
<idno type="wicri:Area/PubMed/Corpus">003530</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003530</idno>
<idno type="wicri:Area/PubMed/Curation">003530</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003530</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003530</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003530</idno>
<idno type="wicri:Area/Ncbi/Merge">002892</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.</title>
<author><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name>
<affiliation wicri:level="3"><nlm:affiliation>DBL-Centre for Health Research and Development, University of Copenhagen, Copenhagen, Denmark. nnielsen@dblnet.dk</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>DBL-Centre for Health Research and Development, University of Copenhagen, Copenhagen</wicri:regionArea>
<placeName><settlement type="city">Copenhague</settlement>
<region type="région" nuts="2">Hovedstaden</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
</author>
<author><name sortKey="Dalgaard, Peter" sort="Dalgaard, Peter" uniqKey="Dalgaard P" first="Peter" last="Dalgaard">Peter Dalgaard</name>
</author>
<author><name sortKey="Krarup, Henrik" sort="Krarup, Henrik" uniqKey="Krarup H" first="Henrik" last="Krarup">Henrik Krarup</name>
</author>
<author><name sortKey="Magnussen, Pascal" sort="Magnussen, Pascal" uniqKey="Magnussen P" first="Pascal" last="Magnussen">Pascal Magnussen</name>
</author>
<author><name sortKey="Magesa, Stephen" sort="Magesa, Stephen" uniqKey="Magesa S" first="Stephen" last="Magesa">Stephen Magesa</name>
</author>
<author><name sortKey="Friis, Henrik" sort="Friis, Henrik" uniqKey="Friis H" first="Henrik" last="Friis">Henrik Friis</name>
</author>
</analytic>
<series><title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="ISSN">0002-9637</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anthelmintics (pharmacology)</term>
<term>CD4-CD8 Ratio</term>
<term>CD4-Positive T-Lymphocytes (cytology)</term>
<term>CD4-Positive T-Lymphocytes (drug effects)</term>
<term>CD8-Positive T-Lymphocytes (cytology)</term>
<term>CD8-Positive T-Lymphocytes (drug effects)</term>
<term>Cross-Over Studies</term>
<term>Diethylcarbamazine (pharmacology)</term>
<term>Double-Blind Method</term>
<term>Elephantiasis, Filarial (complications)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>HIV Infections (complications)</term>
<term>HIV Infections (immunology)</term>
<term>HIV Infections (virology)</term>
<term>HIV-1</term>
<term>Humans</term>
<term>Placebos</term>
<term>Tanzania</term>
<term>Viral Load</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Antihelminthiques (pharmacologie)</term>
<term>Charge virale</term>
<term>Diéthylcarbamazine (pharmacologie)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (immunologie)</term>
<term>Infections à VIH (virologie)</term>
<term>Lymphocytes T CD4+ ()</term>
<term>Lymphocytes T CD4+ (cytologie)</term>
<term>Lymphocytes T CD8+ ()</term>
<term>Lymphocytes T CD8+ (cytologie)</term>
<term>Méthode en double aveugle</term>
<term>Placebo</term>
<term>Rapport CD4-CD8</term>
<term>Tanzanie</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Études croisées</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anthelmintics</term>
<term>Diethylcarbamazine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Tanzania</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Lymphocytes T CD4+</term>
<term>Lymphocytes T CD8+</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>CD8-Positive T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>CD8-Positive T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antihelminthiques</term>
<term>Diéthylcarbamazine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>CD4-CD8 Ratio</term>
<term>Cross-Over Studies</term>
<term>Double-Blind Method</term>
<term>HIV-1</term>
<term>Humans</term>
<term>Placebos</term>
<term>Viral Load</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Charge virale</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Lymphocytes T CD4+</term>
<term>Lymphocytes T CD8+</term>
<term>Méthode en double aveugle</term>
<term>Placebo</term>
<term>Rapport CD4-CD8</term>
<term>Tanzanie</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
<term>Études croisées</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We assessed the effect of anti-filarial treatment (diethylcarbamazine, DEC) on HIV load, CD4%, and CD4/CD8 ratio in HIV-positive individuals with and without infection with the filarial parasite Wuchereria bancrofti in a randomized, double-blind, placebo-controlled cross-over trial. The study was conducted in Tanga Region, Tanzania, in 2002 and involved 27 adults. A significant decrease in HIV load (54%) and an insignificant increase in CD4% were observed in the HIV-positive individuals with filarial co-infection at 12 weeks after treatment. HIV load and CD4% both increased, although not statistically significantly, in the HIV-positive individuals without filarial infection. The findings suggest that DEC affected HIV load through its effect on the filarial infection rather than through a direct (pharmacodynamic) effect on HIV. Global efforts to control lymphatic filariasis by annual mass treatment with DEC may have a beneficial effect on the HIV/AIDS epidemic in areas where HIV and lymphatic filariasis co-exist.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17827369</PMID>
<DateCreated><Year>2007</Year>
<Month>09</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2007</Year>
<Month>11</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9637</ISSN>
<JournalIssue CitedMedium="Print"><Volume>77</Volume>
<Issue>3</Issue>
<PubDate><Year>2007</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am. J. Trop. Med. Hyg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.</ArticleTitle>
<Pagination><MedlinePgn>507-13</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We assessed the effect of anti-filarial treatment (diethylcarbamazine, DEC) on HIV load, CD4%, and CD4/CD8 ratio in HIV-positive individuals with and without infection with the filarial parasite Wuchereria bancrofti in a randomized, double-blind, placebo-controlled cross-over trial. The study was conducted in Tanga Region, Tanzania, in 2002 and involved 27 adults. A significant decrease in HIV load (54%) and an insignificant increase in CD4% were observed in the HIV-positive individuals with filarial co-infection at 12 weeks after treatment. HIV load and CD4% both increased, although not statistically significantly, in the HIV-positive individuals without filarial infection. The findings suggest that DEC affected HIV load through its effect on the filarial infection rather than through a direct (pharmacodynamic) effect on HIV. Global efforts to control lymphatic filariasis by annual mass treatment with DEC may have a beneficial effect on the HIV/AIDS epidemic in areas where HIV and lymphatic filariasis co-exist.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nielsen</LastName>
<ForeName>Nina O</ForeName>
<Initials>NO</Initials>
<AffiliationInfo><Affiliation>DBL-Centre for Health Research and Development, University of Copenhagen, Copenhagen, Denmark. nnielsen@dblnet.dk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Simonsen</LastName>
<ForeName>Paul E</ForeName>
<Initials>PE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dalgaard</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Krarup</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Magnussen</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Magesa</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Friis</LastName>
<ForeName>Henrik</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000871">Anthelmintics</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010919">Placebos</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000871" MajorTopicYN="N">Anthelmintics</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016516" MajorTopicYN="N">CD4-CD8 Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019562" MajorTopicYN="Y">Viral Load</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>11</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>9</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17827369</ArticleId>
<ArticleId IdType="pii">77/3/507</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Danemark</li>
</country>
<region><li>Hovedstaden</li>
</region>
<settlement><li>Copenhague</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Dalgaard, Peter" sort="Dalgaard, Peter" uniqKey="Dalgaard P" first="Peter" last="Dalgaard">Peter Dalgaard</name>
<name sortKey="Friis, Henrik" sort="Friis, Henrik" uniqKey="Friis H" first="Henrik" last="Friis">Henrik Friis</name>
<name sortKey="Krarup, Henrik" sort="Krarup, Henrik" uniqKey="Krarup H" first="Henrik" last="Krarup">Henrik Krarup</name>
<name sortKey="Magesa, Stephen" sort="Magesa, Stephen" uniqKey="Magesa S" first="Stephen" last="Magesa">Stephen Magesa</name>
<name sortKey="Magnussen, Pascal" sort="Magnussen, Pascal" uniqKey="Magnussen P" first="Pascal" last="Magnussen">Pascal Magnussen</name>
<name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name>
</noCountry>
<country name="Danemark"><region name="Hovedstaden"><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002892 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002892 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:17827369 |texte= Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17827369" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |